Illumina Off 7.8% Premarket After Roche Talks Down Deal
January 07 2013 - 09:10AM
Dow Jones News
Illumina Inc. (ILMN) fell back 7.8% in premarket trading Monday
after Roche Holding (RHHBY) Chairman Franz Humer said in an
interview that the company doesn't plan to buy the gene sequencing
specialist.
"Illumina is definitely off the table," Humer said in an
interview published Sunday. Shares of Illumina fell to $50.50 in
recent premarket trading. Roche had approached Illumina with a
buyout offer of $6.8 billion last year, but the company was
rebuffed.
-Write to Steve Gelsi at sgelsi@marketwatch.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Illumina (NASDAQ:ILMN)
Historical Stock Chart
From Feb 2024 to Mar 2024
Illumina (NASDAQ:ILMN)
Historical Stock Chart
From Mar 2023 to Mar 2024